Amgen's Enbrel Does Not Infringe Ariad Patent: Judge
A Delaware judge on Friday granted Amgen Inc. summary judgment of noninfringement in a "convoluted" patent case against Ariad Pharmaceuticals Inc. over an arthritis treatment patent....To view the full article, register now.
Already a subscriber? Click here to view full article